Mats Wahlstrom - 01 Feb 2024 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role: Director
Signature: /s/ Bryan McMichael, as Attorney-in-Fact for Mats Wahlstrom
Issuer symbol: CHRS
Transactions as of: 01 Feb 2024
Net transactions value: +$100,000
Form type: 4
Filing time: 05 Feb 2024, 19:03:30 UTC
Previous filing: 14 Aug 2023
Next filing: 15 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CHRS	Common Stock	Options Exercise	$25,000	+14,997	+37%	$1.67	54,997	01 Feb 2024	Direct	F1
transaction	CHRS	Common Stock	Options Exercise	$75,000	+44,991	+82%	$1.67	99,988	01 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CHRS	Stock Option (Right to Buy)	Options Exercise	$0	-14,997	-100%	$0.000000^*	0	01 Feb 2024	Common Stock	14,997	$1.67	Direct	F2
transaction	CHRS	Stock Option (Right to Buy)	Options Exercise	$0	-44,991	-100%	$0.000000^*	0	01 Feb 2024	Common Stock	44,991	$1.67	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price.
F2	The option is fully vested and exercisable.